Abilify and Insomnia - a phase IV clinical study of FDA data
Insomnia is found among people who take Abilify, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Abilify and have Insomnia. It is created by eHealthMe based on reports of 90,519 people who have side effects when taking Abilify from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
90,519 people reported to have side effects when taking Abilify.
Among them, 3,232 people (3.57%) have Insomnia.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 94,585 Abilify users for its effectiveness, alternative drugs and more.
What is Insomnia?
Insomnia (sleeplessness) is found to be associated with 4,745 drugs and 5,047 conditions by eHealthMe.
Number of Abilify and Insomnia reports submitted per year:
Time on Abilify when people have Insomnia *:
Gender of people who have Insomnia when taking Abilify*:
Age of people who have Insomnia when taking Abilify *:
Common drugs people take besides Abilify *:
Common side effects people have besides Insomnia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Insomnia?Check whether Insomnia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How severe was Insomnia and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
- Insomnia and drugs with ingredients of aripiprazole (3,953 reports)
Alternative drugs to, pros and cons of Abilify:
- Abilify (94,585 reports)
Common Abilify side effects:
- Weight increased: 6,390 reports
- Stress and anxiety: 5,096 reports
- Drug ineffective: 4,877 reports
- Fatigue (feeling of tiredness): 3,524 reports
- Suicidal ideation: 3,504 reports
- Depression: 3,379 reports
- Insomnia (sleeplessness): 3,232 reports
Browse all side effects of Abilify:a b c d e f g h i j k l m n o p q r s t u v w x y z
Insomnia treatments and more:
- Insomnia (389,056 reports)
COVID vaccines that are related to Insomnia:
- Insomnia in Moderna COVID Vaccine
- Insomnia in Pfizer BioNTech Covid Vaccine
- Insomnia in Johnson and Johnson Covid Vaccine
Common drugs associated with Insomnia:
- Prednisone: 11,566 reports
- Aspirin: 10,926 reports
- Lyrica: 10,535 reports
- Cymbalta: 9,690 reports
- Seroquel: 7,933 reports
- Synthroid: 7,613 reports
- Methotrexate: 7,563 reports
- Humira: 7,415 reports
- Omeprazole: 7,192 reports
- Gabapentin: 7,176 reports
All the drugs that are associated with Insomnia:
- Insomnia (4,745 drugs)
Common conditions associated with Insomnia:
- Depression: 16,686 reports
- Pain: 12,964 reports
- Multiple sclerosis: 12,002 reports
- High blood pressure: 11,095 reports
- Rheumatoid arthritis: 10,870 reports
All the conditions that are associated with Insomnia:
- Insomnia (5,047 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Alvesco and Hypothyroidism - 6 seconds ago
- Celebrex and Rhabdomyolysis - 15 seconds ago
- Olmesartan Medoxomil vs. Clonazepam - 16 seconds ago
- Celiac Disease - Sprue and drugs of ingredients of mirtazapine - 19 seconds ago
- Olmesartan Medoxomil vs. Furosemide - 30 seconds ago
- Isoptin Sr vs. Olmesartan Medoxomil - 32 seconds ago
- Olmesartan Medoxomil vs. Klor-Con M20 - 36 seconds ago
- Aromasin and Disease Progression - 39 seconds ago
- Linzess and Feeling Jittery - 41 seconds ago
- Keppra and Isentress drug interaction - 45 seconds ago